Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

SERUM PARAOXONASE ACTIVITY AND OXIDATIVE STRESS IN METABOLIC SYNDROME.

View through CrossRef
Metabolic syndrome is a group of risk factors that increase the risk of developing heart disease, stroke and Type II Diabetes. It`s also known as Insulin Resistance Syndrome.MES is known to be associated with Oxidative stress. The enzyme paraoxonase being antiatherogenic and sensitive to oxidative stress was intriguing in MES. This study was conducted with objectives to determine paraoxonase activity in MES and to correlate paraoxonase activity to oxidative stress in MES. In this study there were a total of 100 male subjects which included 50 healthy male as control and 50 male with MES without complications. Serum paraoxonase (PON) is an enzyme that helps protect the body from oxidative damage, and may help prevent cardiovascular disease.PON hydrolyzes lipid peroxidase and prevent phospholipids from building up in oxidized low-density lipoprotein (LDL). It also hydrolyzes homocysteine thiolactone, which protects against N_homocysteinylation. PON is associated with atherosclerosis and coronary artery disease, endocrine disorders and liver disease. Serum malondialdehyde (MDA) is a biomarker of oxidative stress. High levels of MDA are associated with various diseases. Our study revealed that serum paraoxonase activity was significantly reduced in MES when compared to controls. Correlation between serum paraoxonase and malondialdehyde with routine biochemistry parameters in both MES and controls was not found to be significant. This study indicated that assessment of serum paraoxonase activity can serve as a predictive factor for atherosclerotic complications in MES where oxidative stress is implicated.
Title: SERUM PARAOXONASE ACTIVITY AND OXIDATIVE STRESS IN METABOLIC SYNDROME.
Description:
Metabolic syndrome is a group of risk factors that increase the risk of developing heart disease, stroke and Type II Diabetes.
It`s also known as Insulin Resistance Syndrome.
MES is known to be associated with Oxidative stress.
The enzyme paraoxonase being antiatherogenic and sensitive to oxidative stress was intriguing in MES.
This study was conducted with objectives to determine paraoxonase activity in MES and to correlate paraoxonase activity to oxidative stress in MES.
In this study there were a total of 100 male subjects which included 50 healthy male as control and 50 male with MES without complications.
Serum paraoxonase (PON) is an enzyme that helps protect the body from oxidative damage, and may help prevent cardiovascular disease.
PON hydrolyzes lipid peroxidase and prevent phospholipids from building up in oxidized low-density lipoprotein (LDL).
It also hydrolyzes homocysteine thiolactone, which protects against N_homocysteinylation.
PON is associated with atherosclerosis and coronary artery disease, endocrine disorders and liver disease.
Serum malondialdehyde (MDA) is a biomarker of oxidative stress.
High levels of MDA are associated with various diseases.
Our study revealed that serum paraoxonase activity was significantly reduced in MES when compared to controls.
Correlation between serum paraoxonase and malondialdehyde with routine biochemistry parameters in both MES and controls was not found to be significant.
This study indicated that assessment of serum paraoxonase activity can serve as a predictive factor for atherosclerotic complications in MES where oxidative stress is implicated.

Related Results

Metabolic syndrome and neuroprotection
Metabolic syndrome and neuroprotection
Introduction: over the years, the prevalence of metabolic syndrome has increased dramatically in developing countries as a major by-product of industrialization. Many factors, such...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
THE COMPLEX RELATIONSHIP OF PARAOXONASE GENE POLYMORPHISMS WITH CORONARY ARTERY DISEASE AND LIPID METABOLISM
THE COMPLEX RELATIONSHIP OF PARAOXONASE GENE POLYMORPHISMS WITH CORONARY ARTERY DISEASE AND LIPID METABOLISM
Cardiovascular disorder (CVD) is one of the major reasons for mortality in developing and developed countries. According to the World Health Organization (WHO), non-communicable di...
The discriminative role of angiopoietin-like protein-3 for metabolic syndrome in polycystic ovary syndrome
The discriminative role of angiopoietin-like protein-3 for metabolic syndrome in polycystic ovary syndrome
SUMMARY OBJECTIVE: Patients with polycystic ovary syndrome face an increased risk of developing metabolic syndrome. Identifying biomarkers that can detect metabolic syndrome in po...
Determinants of Metabolic Syndrome among Malaysian Government Employees
Determinants of Metabolic Syndrome among Malaysian Government Employees
Introduction: The metabolic syndrome comprises a collection of cardiovascular disease risks, which has been demonstrated to predict type 2 diabetes mellitus and cardiovascular dise...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Effect of Menopause and Hypertriglyceridemia on Lipid Transfer and Paraoxonase Activity in Diabetic Women
Effect of Menopause and Hypertriglyceridemia on Lipid Transfer and Paraoxonase Activity in Diabetic Women
Introduction. The high prevalence of type 2 diabetes mellitus (DM2) and cardiovascular atherosclerotic complications are increasing in women after menopause. Studies have shown tha...
Novel Metabolic Panel in Metabolic Syndrome
Novel Metabolic Panel in Metabolic Syndrome
MetS is a multifaceted disease that embraces multiple disorders such as obesity, hyperlipidemia, hyperglycemia, insulin resistance, and hypertension. These disorders are characteri...

Back to Top